A consistent finding of many studies describing the spectrum of mutant phenylalanine hydroxylase (PAH) alleles underlying hyperphenylalaninemia is the impossibility of achieving a 100% mutation ascertainment rate using conventional gene-scanning methods. These methods include denaturing gradient gel electrophoresis (DGGE), denaturing high performance liquid chromatography (DHPLC), and direct sequencing. In recent years, it has been shown that a significant pro-portion of undetermined alleles consist of large deletions overlapping one or more exons. These deletions have been difficult to detect in compound heterozygotes using gene-scanning methods due to a masking effect of the non-deleted allele. To date, no systematic search has been carried out for such exon deletions in Italian patients with phenylketonuria or mild hyperphenylalaninemia. We used multiplex ligation-dependent probe amplification (MLPA), comparative multiplex dosage analysis (CMDA), and real-time PCR to search for both large deletions and duplications of the phenylalanine hydroxylase gene in Italian hyperphenylalaninemia patients. Four deletions removing different phenylalanine hydroxylase (PAH) gene exons were identified in 12 patients. Two of these deletions involving exons 4-5-6-7-8 (systematic name c.353-?_912 + ?del) and exon 6 (systematic name c.510-?_706 + ?del) have not been reported previously. In this study, we show that exon deletion of the PAH gene accounts for 1.7% of all mutant PAH alleles in Italian hyperphenylalaninemics.

Exon deletions of the phenylalanine hydroxylase gene in Italian hyperphenylalaninemics / Francesco, Cali; Giuseppa, Ruggeri; Mirella, Vinci; Concetta, Meli; Carducci, Carla; Leuzzi, Vincenzo; Pozzessere, Simone; Pietro, Schinocca; Alda, Ragalmuto; Valeria, Chiavetta; Salvatore, Micciche; Valentino, Romano. - In: EXPERIMENTAL AND MOLECULAR MEDICINE. - ISSN 1226-3613. - 42:2(2010), pp. 81-86. [10.3858/emm.2010.42.2.009]

Exon deletions of the phenylalanine hydroxylase gene in Italian hyperphenylalaninemics

CARDUCCI, Carla;LEUZZI, Vincenzo;POZZESSERE, SIMONE;
2010

Abstract

A consistent finding of many studies describing the spectrum of mutant phenylalanine hydroxylase (PAH) alleles underlying hyperphenylalaninemia is the impossibility of achieving a 100% mutation ascertainment rate using conventional gene-scanning methods. These methods include denaturing gradient gel electrophoresis (DGGE), denaturing high performance liquid chromatography (DHPLC), and direct sequencing. In recent years, it has been shown that a significant pro-portion of undetermined alleles consist of large deletions overlapping one or more exons. These deletions have been difficult to detect in compound heterozygotes using gene-scanning methods due to a masking effect of the non-deleted allele. To date, no systematic search has been carried out for such exon deletions in Italian patients with phenylketonuria or mild hyperphenylalaninemia. We used multiplex ligation-dependent probe amplification (MLPA), comparative multiplex dosage analysis (CMDA), and real-time PCR to search for both large deletions and duplications of the phenylalanine hydroxylase gene in Italian hyperphenylalaninemia patients. Four deletions removing different phenylalanine hydroxylase (PAH) gene exons were identified in 12 patients. Two of these deletions involving exons 4-5-6-7-8 (systematic name c.353-?_912 + ?del) and exon 6 (systematic name c.510-?_706 + ?del) have not been reported previously. In this study, we show that exon deletion of the PAH gene accounts for 1.7% of all mutant PAH alleles in Italian hyperphenylalaninemics.
2010
phenylalanine hydroxylase; phenylketonurias; ligase chain reaction; gene deletion; gene dosage
01 Pubblicazione su rivista::01a Articolo in rivista
Exon deletions of the phenylalanine hydroxylase gene in Italian hyperphenylalaninemics / Francesco, Cali; Giuseppa, Ruggeri; Mirella, Vinci; Concetta, Meli; Carducci, Carla; Leuzzi, Vincenzo; Pozzessere, Simone; Pietro, Schinocca; Alda, Ragalmuto; Valeria, Chiavetta; Salvatore, Micciche; Valentino, Romano. - In: EXPERIMENTAL AND MOLECULAR MEDICINE. - ISSN 1226-3613. - 42:2(2010), pp. 81-86. [10.3858/emm.2010.42.2.009]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/228093
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 15
social impact